ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
A Chinese trial of over 11,000 hypertensive patients found intensive blood pressure control below 120 mm Hg safe for cognition and reduced cardiovascular events.
A Chinese trial of over 11,000 hypertensive patients found intensive blood pressure control below 120 mm Hg safe for cognition and reduced cardiovascular events.
A Chinese trial of over 11,000 hypertensive patients found intensive blood pressure control below 120 mm Hg safe for cognition and reduced cardiovascular events.
A Chinese trial of over 11,000 hypertensive patients found intensive blood pressure control below 120 mm Hg safe for cognition and reduced cardiovascular events.
A Chinese trial of over 11,000 hypertensive patients found intensive blood pressure control below 120 mm Hg safe for cognition and reduced cardiovascular events.
September 28, 2023 2 min read Source/Disclosures Published by: Disclosures: The authors report no relevant financial disclosures. ADD TOPIC TO
Read More
In this photo illustration, Farxiga is made available to customers at the New City Halsted Pharmacy on August 29, 2023
Read More
How does Dr. Greger pressure steam his greens? In a review of more than one hundred articles about the effects
Read More
September 28, 2023 2 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on
Read More
From the start of the second Republican presidential primary debate of the 2024 campaign, the seven candidates on stage were
Read More
St. Louis’ largest health system, BJC HealthCare, plans to merge with Kansas City’s second-largest, Saint Luke’s Health System, uniting more
Read More
Stephanie Stephens As Medicare Advantage continues to gain popularity among seniors, three Southern California companies are pioneering new types of
Read More
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity
Read More
September 27, 2023 2 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on
Read More
Schott Pharma debuted on the Frankfurt stock exchange on Thursday at 30 euros per share, trading well above analyst expectations.
Read More
